Hydroxyurea (hydroxycarbamide) for sickle cell disease - Coc | Figure 1
%27%3e%3cg%20id=%27Group-14%27%20transform=%27translate(13.000000,%20103.176124)%27%3e%3cg%20id=%27Group-Copy-5%27%20transform=%27translate(0.000000,%20182.676124)%27%3e%3crect%20id=%27Rectangle-8%27%20fill=%27%23E2E0DE%27%20x=%270%27%20y=%270%27%20width=%2736%27%20height=%2736%27%20rx=%2718%27%3e%3c/rect%3e%3cpath%20d=%27M28,27.6503435%20C28,22.127496%2023.5228474,17.6503435%2018,17.6503435%20C12.4771525,17.6503435%208,22.127496%208,27.6503435%20M18,16.3472505%20C20.8165136,16.3472505%2023.099749,14.0640151%2023.099749,11.2475015%20C23.099749,8.43098783%2020.8165136,6.1477524%2018,6.1477524%20C15.1834863,6.1477524%2012.9002509,8.43098783%2012.9002509,11.2475015%20C12.9002509,14.0640151%2015.1834863,16.3472505%2018,16.3472505%20Z%27%20id=%27Combined-Shape%27%20fill=%27%23FFFFFF%27%20fill-rule=%27nonzero%27%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Hydroxyurea (hydroxycarbamide) for sickle cell disease - Cochrane Review
There is evidence to suggest that hydroxyurea may be effective in decreasing the frequency of pain episodes and other acute complications in adults and children with sickle cell anaemia of HbSS or HbSβºthal genotypes and in preventing life‐threatening neurological events in those with sickle cell anaemia at risk of primary stroke by maintaining transcranial Doppler velocities.
Diagnosis added by author
Diagnosis: sickle cell
More about this case
Resolved
Why you should join Figure 1
- Share your knowledge with our global community of healthcare professionals
- Get help from experts in your field
- Learn from our library of real-world cases and quizzes
Similar cases
Sickle blood cells (left) normal blood cells (right)
Clubbing in a 29yo M with sickle cell anemia
Bony infarcts in a 21 yo male with sickle cells anaemia.
Peripheral blood smear, 26M, AA, came in for assault. No PMH with hospital...
A 52-year-old man presented with a 20-minute history...
A 28-year-old woman presented with a 3-day history...